Form 8-K - Current report:
SEC Accession No. 0001193125-19-212557
Filing Date
2019-08-05
Accepted
2019-08-05 08:00:55
Documents
3
Period of Report
2019-08-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d757827d8k.htm 8-K 16865
2 EX-99.1 d757827dex991.htm EX-99.1 14414
3 GRAPHIC g757827g91a23.jpg GRAPHIC 4459
  Complete submission text file 0001193125-19-212557.txt   38804
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 19997600
SIC: 2834 Pharmaceutical Preparations